MedTrace Logo

Autonomic Neuromodulation by Transcutaneous Nerve Stimulation in Acute Ischaemic Stroke.

NCT05417009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-07-14

Study results available
· View outcomes & findings →

Summary

Autonomic modulation by transcutaneous vagal nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: a phase IIa, sham controlled randomised trial.

Conditions

  • Ischemic Stroke
  • Thrombotic Stroke
  • Autonomic Dysfunction
  • Autonomic Imbalance

Interventions

DEVICE

trans-cutaneous auricular sensory stimulation

Transcutaneous auricular sensory stimulation

Sponsors & Collaborators

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Gareth L Ackland, PhD FRCA · William Harvey Research Institute, Queen Mary University of London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-26
Primary Completion
2023-07-21
Completion
2023-07-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05417009 on ClinicalTrials.gov